Migraine Treatment Market
Migraine Treatment Market Forecasts to 2030 - Global Analysis By Treatment Type (Pharmacological Treatments and Non-Pharmacological Treatments), Drug Class, Route Of Administration, Age Group, Severity, End User and By Geography
According to Stratistics MRC, the Global Migraine Treatment Market is accounted for $3.46 billion in 2024 and is expected to reach $4.52 billion by 2030 growing at a CAGR of 6.2% during the forecast period. Migraine treatment refers to medical strategies aimed at relieving the symptoms and preventing future attacks of migraine headaches, which are characterized by intense, recurring pain often accompanied by nausea, vomiting, and sensitivity to light and sound. Treatment options include acute treatments, such as pain relief medications (NSAIDs, triptans, or painkillers), and preventive treatments, like beta-blockers, anticonvulsants, or antidepressants.
According to the Migraine Research Foundation, migraine is the third most common disease in the world, affecting an estimated 1 billion people globally.
Market Dynamics:
Driver:
Rising prevalence of migraines
As more individuals experience frequent or chronic migraines, there is a greater demand for effective treatments, leading to market expansion. Factors such as stress, lifestyle changes, and increasing awareness contribute to the growing number of migraine sufferers globally. This increased patient population encourages pharmaceutical companies to develop innovative treatments, including new medications, devices, and therapies. Additionally, the rising awareness about treatment options prompts healthcare providers to offer specialized care, further fueling market demand for both acute and preventive migraine treatments.
Restraint:
Adverse effects of migraine drugs
Adverse effects of migraine drugs, such as nausea, dizziness, fatigue, and potential cardiovascular issues, can discourage patient adherence to treatment plans. Medications like triptans and certain preventive drugs may cause side effects that outweigh their benefits for some individuals. These adverse reactions can lead to discontinuation of prescribed treatments, reduced efficacy, and increased healthcare costs due to the need for alternative therapies. This hampers the migraine treatment market by limiting the widespread use of certain drugs.
Opportunity:
Rising popularity of virtual consultations
Telemedicine allows individuals, especially in remote or underserved areas, to consult with healthcare professionals without the need for in-person visits. This is particularly beneficial for migraine patients who require regular follow-ups, medication adjustments, and guidance on treatment plans. Virtual consultations enable timely diagnosis and prescription of medications, such as CGRP inhibitors or other migraine-specific treatments, thus enhancing treatment adherence and reducing healthcare barriers. The integration of digital health tools further supports personalized care, fueling market expansion.
Threat:
Treatment resistance
Treatment resistance in migraine drugs occurs when patients do not respond to standard therapies, which can be due to genetic factors, medication overuse, or the body's adaptation to treatments over time. This resistance leads to patient dissatisfaction and increased demand for alternative therapies. It also drives up healthcare costs, as patients may need to try multiple treatments before finding one that works. Additionally, treatment resistance may deter new patients from seeking care, impacting market growth and treatment adherence.
Covid-19 Impact
The covid-19 pandemic significantly impacted the migraine treatment market, with disruptions in healthcare services, delays in medical procedures, and limited access to treatment centers. Lockdowns and increased stress led to a rise in migraine occurrences, yet many patients faced difficulties in obtaining treatments. Telemedicine emerged as a key solution, allowing virtual consultations for prescribing medications. Despite these challenges, the market saw growth in demand for digital health solutions and at-home migraine management options, shaping future treatment trends post-pandemic.
The chronic migraine segment is expected to be the largest during the forecast period
The chronic migraine segment is predicted to secure the largest market share throughout the forecast period. In chronic migraine treatment, the focus is on managing frequent, long-lasting migraine attacks occurring at least 15 days per month. Preventive treatments, such as CGRP inhibitors, Botox injections, anticonvulsants, and beta-blockers, are commonly prescribed to reduce the frequency and severity of attacks. Additionally, early intervention can prevent the progression of episodic migraines to chronic forms, offering significant health and economic benefits for patients.
The neurologists segment is expected to have the highest CAGR during the forecast period
The neurologists segment is anticipated to witness the highest CAGR during the forecast period. Migraine treatment by neurologists involves a comprehensive approach, including accurate diagnosis, personalized treatment plans, and ongoing management. They provide precise diagnosis, access to the latest treatment options, and expert management of chronic or severe cases. This specialized care improves treatment efficacy, reduces migraine frequency, and enhances overall quality of life for patients.
Region with largest share:
Asia Pacific is expected to register the largest market share during the forecast period due to increasing awareness, rising healthcare access, and a growing prevalence of migraine-related conditions. Rapid urbanization, high stress levels, and changing lifestyles contribute to a rise in migraine cases. Countries like China, India, and Japan are seeing rising demand for both acute and preventive treatments, including medications, therapies, and devices. The market is further supported by government initiatives and improving healthcare infrastructure across the region.
Region with highest CAGR:
North America is projected to witness the highest CAGR over the forecast period driven by high awareness, advanced healthcare infrastructure, and increasing migraine prevalence. In the U.S. and Canada, the market is expanding due to the availability of innovative treatments, including CGRP inhibitors, botox injections, and digital therapeutics. The market also benefits from growing telemedicine adoption and access to personalized care. Key players are focusing on novel therapies and preventative solutions to meet the region's evolving needs.
Key players in the market
Some of the key players profiled in the Migraine Treatment Market include Amgen Inc., Eli Lilly and Co., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Pfizer Inc., Johnson & Johnson, GlaxoSmithKline plc, Allergan, Sanofi S.A., Merck & Co., Inc., Dr. Reddy's Laboratories, Cipla Limited, Mylan N.V., Satsuma Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company, Lundbeck A/S, Atogepant, Zosano Pharma Corporation and Kalydor.
Key Developments:
In November 2023, Dr. Reddy’s Laboratories launched Nerivio, a state-of-the-art United States Food and Drug Administration (USFDA) approved wearable therapy device for drug-free management of migraine, in the domestic market. It is to be used within 60 minutes of onset of headache for acute treatment of migraine or every alternate day.
In March 2023, Pfizer announced that it has received FDA approval for Zavegepant, a CGRP receptor antagonist nasal spray, marking the first nasal spray in this category for acute migraine treatment. It offers a fast-acting solution, with studies showing significant improvements in pain relief within 2 hours of use.
Treatment Types Covered:
• Pharmacological Treatments
• Non-Pharmacological Treatments
Drug Classes Covered:
• Triptans
• Ergotamine Derivatives
• Calcitonin Gene-Related Peptide (CGRP) Inhibitors
• Anti-depressants & Anti-epileptic Drugs
• Botulinum Toxin
• Beta-blockers
• Calcium Channel Blockers
• Other Drug Classes
Route Of Administrations Covered:
• Oral
• Injection
• Intranasal
• Transdermal
Age Groups Covered:
• Pediatric
• Adult
• Geriatric
Severities Covered:
• Chronic Migraine
• Episodic Migraine
End Users Covered:
• General Practitioners
• Neurologists
• Homecare Settings
• Nursing Homes
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Migraine Treatment Market, By Treatment Type
5.1 Introduction
5.2 Pharmacological Treatments
5.2.1 Abortive Medications
5.2.2 Preventive Medications
5.2.3 Over-the-counter Medications
5.3 Non-Pharmacological Treatments
5.3.1 Behavioral Therapy
5.3.2 Acupuncture
5.3.3 Transcranial Magnetic Stimulation (TMS)
5.3.4 Deep Brain Stimulation (DBS)
5.3.5 Nerve Blocks
5.3.6 Relaxation Techniques
6 Global Migraine Treatment Market, By Drug Class
6.1 Introduction
6.2 Triptans
6.3 Ergotamine Derivatives
6.4 Calcitonin Gene-Related Peptide (CGRP) Inhibitors
6.5 Anti-depressants & Anti-epileptic Drugs
6.6 Botulinum Toxin
6.7 Beta-blockers
6.8 Calcium Channel Blockers
6.9 Other Drug Classes
7 Global Migraine Treatment Market, By Route Of Administration
7.1 Introduction
7.2 Oral
7.3 Injection
7.4 Intranasal
7.5 Transdermal
8 Global Migraine Treatment Market, By Age Group
8.1 Introduction
8.2 Pediatric
8.3 Adult
8.4 Geriatric
9 Global Migraine Treatment Market, By Severity
9.1 Introduction
9.2 Chronic Migraine
9.3 Episodic Migraine
10 Global Migraine Treatment Market, By End User
10.1 Introduction
10.2 General Practitioners
10.3 Neurologists
10.4 Homecare Settings
10.5 Nursing Homes
10.6 Other End Users
11 Global Migraine Treatment Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Amgen Inc.
13.2 Eli Lilly and Co.
13.3 AbbVie Inc.
13.4 Teva Pharmaceutical Industries Ltd.
13.5 Novartis AG
13.6 Pfizer Inc.
13.7 Johnson & Johnson
13.8 GlaxoSmithKline plc
13.9 Allergan
13.10 Sanofi S.A.
13.11 Merck & Co., Inc.
13.12 Dr. Reddy's Laboratories
13.13 Cipla Limited
13.14 Mylan N.V.
13.15 Satsuma Pharmaceuticals Inc.
13.16 Biohaven Pharmaceutical Holding Company
13.17 Lundbeck A/S
13.18 Atogepant
13.19 Zosano Pharma Corporation
13.20 Kalydor
List of Tables
1 Global Migraine Treatment Market Outlook, By Region (2022-2030) ($MN)
2 Global Migraine Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
3 Global Migraine Treatment Market Outlook, By Pharmacological Treatments (2022-2030) ($MN)
4 Global Migraine Treatment Market Outlook, By Abortive Medications (2022-2030) ($MN)
5 Global Migraine Treatment Market Outlook, By Preventive Medications (2022-2030) ($MN)
6 Global Migraine Treatment Market Outlook, By Over-the-counter Medications (2022-2030) ($MN)
7 Global Migraine Treatment Market Outlook, By Non-Pharmacological Treatments (2022-2030) ($MN)
8 Global Migraine Treatment Market Outlook, By Behavioral Therapy (2022-2030) ($MN)
9 Global Migraine Treatment Market Outlook, By Acupuncture (2022-2030) ($MN)
10 Global Migraine Treatment Market Outlook, By Transcranial Magnetic Stimulation (TMS) (2022-2030) ($MN)
11 Global Migraine Treatment Market Outlook, By Deep Brain Stimulation (DBS) (2022-2030) ($MN)
12 Global Migraine Treatment Market Outlook, By Nerve Blocks (2022-2030) ($MN)
13 Global Migraine Treatment Market Outlook, By Relaxation Techniques (2022-2030) ($MN)
14 Global Migraine Treatment Market Outlook, By Drug Class (2022-2030) ($MN)
15 Global Migraine Treatment Market Outlook, By Triptans (2022-2030) ($MN)
16 Global Migraine Treatment Market Outlook, By Ergotamine Derivatives (2022-2030) ($MN)
17 Global Migraine Treatment Market Outlook, By Calcitonin Gene-Related Peptide (CGRP) Inhibitors (2022-2030) ($MN)
18 Global Migraine Treatment Market Outlook, By Anti-depressants & Anti-epileptic Drugs (2022-2030) ($MN)
19 Global Migraine Treatment Market Outlook, By Botulinum Toxin (2022-2030) ($MN)
20 Global Migraine Treatment Market Outlook, By Beta-blockers (2022-2030) ($MN)
21 Global Migraine Treatment Market Outlook, By Calcium Channel Blockers (2022-2030) ($MN)
22 Global Migraine Treatment Market Outlook, By Other Drug Classes (2022-2030) ($MN)
23 Global Migraine Treatment Market Outlook, By Route Of Administration (2022-2030) ($MN)
24 Global Migraine Treatment Market Outlook, By Oral (2022-2030) ($MN)
25 Global Migraine Treatment Market Outlook, By Injection (2022-2030) ($MN)
26 Global Migraine Treatment Market Outlook, By Intranasal (2022-2030) ($MN)
27 Global Migraine Treatment Market Outlook, By Transdermal (2022-2030) ($MN)
28 Global Migraine Treatment Market Outlook, By Age Group (2022-2030) ($MN)
29 Global Migraine Treatment Market Outlook, By Pediatric (2022-2030) ($MN)
30 Global Migraine Treatment Market Outlook, By Adult (2022-2030) ($MN)
31 Global Migraine Treatment Market Outlook, By Geriatric (2022-2030) ($MN)
32 Global Migraine Treatment Market Outlook, By Severity (2022-2030) ($MN)
33 Global Migraine Treatment Market Outlook, By Chronic Migraine (2022-2030) ($MN)
34 Global Migraine Treatment Market Outlook, By Episodic Migraine (2022-2030) ($MN)
35 Global Migraine Treatment Market Outlook, By End User (2022-2030) ($MN)
36 Global Migraine Treatment Market Outlook, By General Practitioners (2022-2030) ($MN)
37 Global Migraine Treatment Market Outlook, By Neurologists (2022-2030) ($MN)
38 Global Migraine Treatment Market Outlook, By Homecare Settings (2022-2030) ($MN)
39 Global Migraine Treatment Market Outlook, By Nursing Homes (2022-2030) ($MN)
40 Global Migraine Treatment Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
